...
机译:同种异体造血干细胞移植单位的2小时间歇性静脉内输注的两小时间歇性静脉输注
Leslie Dan Faculty of Pharmacy University of Toronto;
Allogeneic Blood and Marrow Transplant Program University Health Network;
Leslie Dan Faculty of Pharmacy University of Toronto;
Department of Pharmacy University Health Network;
Department of Pharmacy University Health Network;
Faculty of Medicine University of Toronto;
Allogeneic Blood and Marrow Transplant Program University Health Network;
Faculty of Medicine University of Toronto;
Faculty of Medicine University of Toronto;
Faculty of Medicine University of Toronto;
Faculty of Medicine University of Toronto;
Faculty of Medicine University of Toronto;
Faculty of Medicine University of Toronto;
机译:同种异体造血干细胞移植单位的2小时间歇性静脉内输注的两小时间歇性静脉输注
机译:异化造血干细胞移植综合静脉内输注在切换过程中影响曲米血液浓度的可变因子分析
机译:唑脂药物对从静脉立法司切换到近日修饰释放的同种异体造血干细胞移植患者静脉立法司后血凝血管素水平的影响
机译:静脉内凋亡细胞输注作为基于细胞的治疗,从而改善造血细胞移植结果
机译:慢性移植物抗宿主病(cGVHD)的同种异体造血干细胞移植的幸存者的症状,功能状态和免疫力改变。
机译:异基因造血细胞移植后儿童从连续静脉输注转为口服后他克莫司亚治疗水平的危险因素
机译:在同种异体造血细胞移植后连续静脉输注对儿童中口服的转化后亚治他克莫司水平的危险因素